Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy P A Vigers

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|December 30, 2003
Multiple active site corrections for docking and virtual screeningGuy P A Vigers, James P Rizzi
Plos One|October 2, 2010
Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibitionWen-I Wu, Walter C Voegtli, Hillary L Sturgis, et al.
Science Signaling|May 10, 2012
An ATP-site on-off switch that restricts phosphatase accessibility of AktKui Lin, Jie Lin, Wen-I Wu, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2014
Synthesis, characterization, and PK/PD studies of a series of spirocyclic pyranochromene BACE1 inhibitorsMatthew Volgraf, Lina Chan, Malcolm P Huestis, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2011
Discovery and SAR of spirochromane Akt inhibitorsNicholas C Kallan, Keith L Spencer, James F Blake, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2010
Discovery of pyrrolopyrimidine inhibitors of AktJames F Blake, Nicholas C Kallan, Dengming Xiao, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2011
Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKARui Xu, Anna Banka, James F Blake, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2010
Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitorsJosef R Bencsik, Dengming Xiao, James F Blake, et al.
Journal of Medicinal Chemistry|September 1, 2012
Discovery and preclinical pharmacology of a selective ATP-competitive Akt inhibitor (GDC-0068) for the treatment of human tumorsJames F Blake, Rui Xu, Josef R Bencsik, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|December 30, 2003
Multiple active site corrections for docking and virtual screeningGuy P A Vigers, James P Rizzi
Plos One|October 2, 2010
Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibitionWen-I Wu, Walter C Voegtli, Hillary L Sturgis, et al.
Science Signaling|May 10, 2012
An ATP-site on-off switch that restricts phosphatase accessibility of AktKui Lin, Jie Lin, Wen-I Wu, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2014
Synthesis, characterization, and PK/PD studies of a series of spirocyclic pyranochromene BACE1 inhibitorsMatthew Volgraf, Lina Chan, Malcolm P Huestis, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2011
Discovery and SAR of spirochromane Akt inhibitorsNicholas C Kallan, Keith L Spencer, James F Blake, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2010
Discovery of pyrrolopyrimidine inhibitors of AktJames F Blake, Nicholas C Kallan, Dengming Xiao, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2011
Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKARui Xu, Anna Banka, James F Blake, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2010
Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitorsJosef R Bencsik, Dengming Xiao, James F Blake, et al.
Journal of Medicinal Chemistry|September 1, 2012
Discovery and preclinical pharmacology of a selective ATP-competitive Akt inhibitor (GDC-0068) for the treatment of human tumorsJames F Blake, Rui Xu, Josef R Bencsik, et al.
Pageof 1